Sign in

CIK 0001796280 · Non-accelerated filer

Oric Pharmaceuticals, Inc.

Sign in to watch
Ticker
ORIC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471787157
Phone
(650) 388-5600
Business address
240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,519,090
in 5 filings, $1.5M under 10b5-1 plans

Net −$1,519,090. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Piscitelli Dominic −$1.4M Chief Financial Officer sold 60% of stake
  2. Heyman Richard A. −$87K Director sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2020-06-09 Kunkel Lori Anne Director Grant or award · Stock Option (right to buy) +28,515 28,515
2020-04-28 COLUMN GROUP II, LP 10% owner Conversion +3,500,000 3,575,000
2020-04-28 COLUMN GROUP II, LP 10% owner Conversion +625,000 4,200,000
2020-04-28 COLUMN GROUP II, LP 10% owner Conversion +416,666 4,616,666
2020-04-28 COLUMN GROUP II, LP 10% owner Conversion +151,515 4,768,181
2020-04-28 COLUMN GROUP II, LP 10% owner Conversion · Series A Preferred Stock −3,500,000 0
2020-04-28 COLUMN GROUP II, LP 10% owner Conversion · Series B Preferred Stock −625,000 0
2020-04-28 COLUMN GROUP II, LP 10% owner Conversion · Series C Preferred Stock −416,666 0
2020-04-28 COLUMN GROUP II, LP 10% owner Conversion · Series D Preferred Stock −151,515 0
2020-04-28 ORBIMED ADVISORS LLC Director Conversion +1,875,000 2,156,250
2020-04-28 ORBIMED ADVISORS LLC Director Conversion +373,356 2,529,606
2020-04-28 ORBIMED ADVISORS LLC Director Conversion +236,111 2,765,717
2020-04-28 ORBIMED ADVISORS LLC Director Conversion · Series B Preferred Stock −1,875,000 0
2020-04-28 ORBIMED ADVISORS LLC Director Conversion · Series C Preferred Stock −373,356 0
2020-04-28 ORBIMED ADVISORS LLC Director Conversion · Series D Preferred Stock −236,111 0
2020-04-28 Topspin Fund L.P. 10% owner Conversion +231,250 231,250
2020-04-28 Topspin Fund L.P. 10% owner Conversion +497,809 729,059
2020-04-28 Topspin Fund L.P. 10% owner Conversion +314,815 1,043,874
2020-04-28 Topspin Fund L.P. 10% owner Conversion +2,268,750 2,268,750
2020-04-28 Topspin Fund L.P. 10% owner Conversion · Series B Preferred Stock −231,250 0

Page 16 of 18 · 353 trades